The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Fluorine in medicinal chemistry
Abstract
It has become evident that fluorinated compounds have a remarkable record in medicinal chemistry and will play a continuing role in providing lead compounds for therapeutic applications. This tutorial review provides a sampling of renowned fluorinated drugs and their mode of action with a discussion clarifying the role and impact of fluorine substitution on drug potency.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
Fluorine in Pharmaceuticals: Looking Beyond Intuition
Müller, K., Faeh, C., & Diederich, F. (2007) · Science · doi:10.1126/science.1131943 · Cited by 6,596
Understanding organofluorine chemistry. An introduction to the C–F bond
O'Hagan, D. (2008) · Chem. Soc. Rev. · doi:10.1039/b711844a · Cited by 4,045
Drucker, D. J., & Nauck, M. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69705-5 · Cited by 3,896
The Many Roles for Fluorine in Medicinal Chemistry
Hagmann, W. K. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800219f · Cited by 3,578
The influence of drug-like concepts on decision-making in medicinal chemistry
Leeson, P. D., & Springthorpe, B. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2445 · Cited by 2,403
Penning, T. D., Talley, J. J., Bertenshaw, S. R., Carter, J. S., Collins, P. W., Docter, S., Graneto, M. J., Lee, L. F., Malecha, J. W., Miyashiro, J. M., et al. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm960803q · Cited by 1,965
Structural mechanism for statin inhibition of HMG-CoA reductase
Istvan, E. S., & Deisenhofer, J. (2001) · Science · doi:10.1126/science.1059344 · Cited by 1,644
Fluorinated pyrimidines, a new class of tumour-inhibitory compounds
HEIDELBERGER, C., CHAUDHURI, N. K., DANNEBERG, P., MOOREN, D., GRIESBACH, L., DUSCHINSKY, R., SCHNITZER, R. J., PLEVEN, E., & SCHEINER, J. (1957) · Nature · doi:10.1038/179663a0 · Cited by 1,603
Fluorine in Medicinal Chemistry
Böhm, H., Banner, D., Bendels, S., Kansy, M., Kuhn, B., Müller, K., Obst‐Sander, U., & Stahl, M. (2004) · ChemBioChem · doi:10.1002/cbic.200301023 · Cited by 1,572
Research works printed but not linked: 15
- Roman, 2003, Eur. J. Pharmacol., 479, 53, 10.1016/j.ejphar.2003.08.056 · doi:10.1016/j.ejphar.2003.08.056
- Robertson, 2005, Eur. J. Cancer, 41, 346, 10.1016/j.ejca.2004.07.035 · doi:10.1016/j.ejca.2004.07.035
- Adkins, 1998, Drugs, 56, 1055, 10.2165/00003495-199856060-00014 · doi:10.2165/00003495-199856060-00014
- Rabel, 2001, AAPS PharmSci, 3, 1, 10.1208/ps030428 · doi:10.1208/ps030428
- Van Niel, 1999, J. Med. Chem., 42, 2087, 10.1021/jm981133m · doi:10.1021/jm981133m
- Jacobs, 1994, J. Med. Chem., 37, 1282, 10.1021/jm00035a008 · doi:10.1021/jm00035a008
- Massa, 2001, Bioorg. Med. Chem. Lett., 11, 1625, 10.1016/S0960-894X(01)00244-X · doi:10.1016/s0960-894x(01)00244-x
- Muller, 1986, J. Pharm. Sci., 75, 987, 10.1002/jps.2600751016 · doi:10.1002/jps.2600751016
- Bannai, 1983, Tetrahedron, 39, 3807, 10.1016/S0040-4020(01)88623-3 · doi:10.1016/s0040-4020(01)88623-3
- Chang, 1997, Prostaglandins, 53, 83, 10.1016/S0090-6980(97)00003-8 · doi:10.1016/s0090-6980(97)00003-8
- Barrett, 1998, J. Am. Chem. Soc., 120, 449, 10.1021/ja973210t · doi:10.1021/ja973210t
- Malet-Martino, 2002, Curr. Med. Chem.: Anti-Cancer Agents, 2, 267
- Barchi, Jr., 1997, J. Biochem. Biophys. Methods, 34, 11, 10.1016/S0165-022X(96)00032-2 · doi:10.1016/s0165-022x(96)00032-2
- Beuthien-Baumann, 2000, Carbohydr. Res., 327, 107, 10.1016/S0008-6215(00)00030-6 · doi:10.1016/s0008-6215(00)00030-6
- Cunningham, 2005, Drug Discovery Today: Technol., 2, 311, 10.1016/j.ddtec.2005.11.003 · doi:10.1016/j.ddtec.2005.11.003
Cited by
Items 101–120 of 120
Copper-catalyzed trifluoromethylation of aryl boronic acids using a CF3+ reagent
Xu, J., Luo, D.-F., Xiao, B., Liu, Z.-J., Gong, T.-J., Fu, Y., & Liu, L. (2011) · Chemical Communications · doi:10.1039/c1cc10359h · Cited by 271
Besset, T., Poisson, T., & Pannecoucke, X. (2014) · Chemistry – A European Journal · doi:10.1002/chem.201404537 · Cited by 269
The Role of the Phosphorus Atom in Drug Design
Rodriguez, J. B., & Gallo‐Rodriguez, C. (2019) · ChemMedChem · doi:10.1002/cmdc.201800693 · Cited by 267
Fluoropolymers: Origin, Production, and Industrial and Commercial Applications
Gardiner, J. (2015) · Australian Journal of Chemistry · doi:10.1071/ch14165 · Cited by 264
Tamoxifen a pioneering drug: An update on the therapeutic potential of tamoxifen derivatives
Shagufta, & Ahmad, I. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.11.056 · Cited by 263
“Magic Chloro”: Profound Effects of the Chlorine Atom in Drug Discovery
Chiodi, D., & Ishihara, Y. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c02015 · Cited by 263
Oh, S. H., Malpani, Y. R., Ha, N., Jung, Y.-S., & Han, S. B. (2014) · Organic Letters · doi:10.1021/ol403716t · Cited by 260
Aromatische Ringe in chemischer und biologischer Erkennung: Energien und Strukturen
Salonen, L. M., Ellermann, M., & Diederich, F. (2011) · Angewandte Chemie · doi:10.1002/ange.201007560 · Cited by 254
Chalcone derivatives and their antibacterial activities: Current development
Xu, M., Wu, P., Shen, F., Ji, J., & Rakesh, K. P. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.103133 · Cited by 254
eToxPred: a machine learning-based approach to estimate the toxicity of drug candidates
Pu, L., Naderi, M., Liu, T., Wu, H.-C., Mukhopadhyay, S., & Brylinski, M. (2019) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-018-0282-6 · Cited by 212
“The presence of fluorine atoms in pharmaceuticals increases their bioavailability by modulating p K a and lipophilicity, as well as by improving their absorption and partitioning into membranes [82].”
BackgroundThe biodegradation vs. biotransformation of fluorosubstituted aromatics
Kiel, M., & Engesser, K.-H. (2015) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-015-6817-5 · Cited by 95
(2023) · doi:10.1021/acs.estlett.3c00108 · Cited by 67
Dawson, D. E., Lau, C., Pradeep, P., Sayre, R. R., Judson, R. S., Tornero-Velez, R., & Wambaugh, J. F. (2023) · Toxics · doi:10.3390/toxics11020098 · Cited by 56
Directed Evolution of a Fluorinase for Improved Fluorination Efficiency with a Non‐native Substrate
Sun, H., Yeo, W. L., Lim, Y. H., Chew, X., Smith, D. J., Xue, B., Chan, K. P., Robinson, R. C., Robins, E. G., Zhao, H., et al. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201606722 · Cited by 54
ATP-Dependent C–F Bond Cleavage Allows the Complete Degradation of 4-Fluoroaromatics without Oxygen
Tiedt, O., Mergelsberg, M., Boll, K., Müller, M., Adrian, L., Jehmlich, N., von Bergen, M., & Boll, M. (2016) · mBio · doi:10.1128/mbio.00990-16 · Cited by 50
Exhaustive Fluorine Scanning toward Potent p53–Mdm2 Antagonists
Huang, Y., Wolf, S., Koes, D., Popowicz, G. M., Camacho, C. J., Holak, T. A., & Dömling, A. (2012) · ChemMedChem · doi:10.1002/cmdc.201100428 · Cited by 49
Chemical modulation of Kv7 potassium channels
Borgini, M., Mondal, P., Liu, R., & Wipf, P. (2021) · RSC Medicinal Chemistry · doi:10.1039/d0md00328j · Cited by 37
Vandeputte, M. M., Glatfelter, G. C., Walther, D., Layle, N. K., St. Germaine, D. M., Ujváry, I., Iula, D. M., Baumann, M. H., & Stove, C. P. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107503 · Cited by 35
Tiedt, O., Mergelsberg, M., Eisenreich, W., & Boll, M. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02579 · Cited by 32
Alam, M. K., Qian, B., Davis, G. B., Donn, M., Kumar, A., Trinchi, A., Kyratzis, I. (., Kirby, J. K., Lan, M., Zhao, H., et al. (2026) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2026.120038 · Cited by 7
Metadata
- Authors
- Purser, S., Moore, P. R., Swallow, S., & Gouverneur, V.
- Venue
- Chem. Soc. Rev.
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2008
- Volume
- 37
- Issue
- 2
- Pages
- 320-330
- ISSN
- 0306-0012 (ISSN-L)
- 1460-4744
- OpenAlex
- W2116087305
- Cited by
- 7,570
- References
- 80
- FWCI
- 4.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.